KR950700292A - 니트로소화방법(Nitrosation process) - Google Patents

니트로소화방법(Nitrosation process)

Info

Publication number
KR950700292A
KR950700292A KR1019940702881A KR19940702881A KR950700292A KR 950700292 A KR950700292 A KR 950700292A KR 1019940702881 A KR1019940702881 A KR 1019940702881A KR 19940702881 A KR19940702881 A KR 19940702881A KR 950700292 A KR950700292 A KR 950700292A
Authority
KR
South Korea
Prior art keywords
formula
compounds
nitrosation process
chem
nitrosation
Prior art date
Application number
KR1019940702881A
Other languages
English (en)
Other versions
KR100261530B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR950700292A publication Critical patent/KR950700292A/ko
Application granted granted Critical
Publication of KR100261530B1 publication Critical patent/KR100261530B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D453/00Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
    • C07D453/02Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Catalysts (AREA)
  • Saccharide Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
KR1019940702881A 1992-02-20 1993-02-11 니트로소화 방법 KR100261530B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB929203688A GB9203688D0 (en) 1992-02-20 1992-02-20 Novel process
GB9203688.8 1992-02-20
PCT/GB1993/000291 WO1993017018A1 (en) 1992-02-20 1993-02-11 Nitrosation process

Publications (2)

Publication Number Publication Date
KR950700292A true KR950700292A (ko) 1995-01-16
KR100261530B1 KR100261530B1 (ko) 2000-08-01

Family

ID=10710781

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019940702881A KR100261530B1 (ko) 1992-02-20 1993-02-11 니트로소화 방법

Country Status (19)

Country Link
US (2) US5545740A (ko)
EP (2) EP0984008A3 (ko)
JP (1) JP3288704B2 (ko)
KR (1) KR100261530B1 (ko)
AT (1) ATE194341T1 (ko)
AU (1) AU669355B2 (ko)
CA (1) CA2131019C (ko)
DE (1) DE69328962T2 (ko)
DK (1) DK0626961T3 (ko)
ES (1) ES2147749T3 (ko)
GB (1) GB9203688D0 (ko)
GR (1) GR3034295T3 (ko)
HK (1) HK1012366A1 (ko)
MX (1) MX9300875A (ko)
NZ (1) NZ246940A (ko)
PT (1) PT626961E (ko)
TW (1) TW224466B (ko)
WO (1) WO1993017018A1 (ko)
ZA (1) ZA931132B (ko)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.
GB9409705D0 (en) * 1994-05-14 1994-07-06 Smithkline Beecham Plc Novel compounds
GB9421472D0 (en) * 1994-10-25 1994-12-07 Smithkline Beecham Plc Novel methods
GB9615628D0 (en) * 1996-07-25 1996-09-04 Smithkline Beecham Plc Formulation
JP2002503224A (ja) * 1997-04-11 2002-01-29 エリ リリー アンド カンパニー 疼痛を処置するための組成物
AU7107998A (en) * 1997-04-11 1998-11-11 Eli Lilly And Company Method for treating schizophrenia
JP2009506069A (ja) 2005-08-26 2009-02-12 ブレインセルス,インコーポレイティド ムスカリン性受容体調節による神経発生
EP2258359A3 (en) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenesis by muscarinic receptor modulation with sabcomelin
AU2006304787A1 (en) 2005-10-21 2007-04-26 Braincells, Inc. Modulation of neurogenesis by PDE inhibition
CA2625210A1 (en) 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US7678808B2 (en) 2006-05-09 2010-03-16 Braincells, Inc. 5 HT receptor mediated neurogenesis
AU2007249399A1 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
EP2068872A1 (en) 2006-09-08 2009-06-17 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1600969A (en) 1977-01-07 1981-10-21 Acf Chemiefarma Nv Heterocyclic compounds
US4937239A (en) * 1989-02-13 1990-06-26 Warner-Lambert Company Azabicycloalkane oxime & azabicycloalkene oxime muscarinic agents
EP0392803B1 (en) * 1989-04-13 2004-06-16 Beecham Group p.l.c. Novel compounds
DK198590D0 (da) * 1990-08-21 1990-08-21 Novo Nordisk As Heterocykliske forbindelser, deres fremstilling og anvendelse
US5418240A (en) 1990-08-21 1995-05-23 Novo Nordisk A/S Heterocyclic compounds and their preparation and use
MX9300875A (es) 1992-02-20 1993-08-31 Smithkline Beecham Plc Procedimiento para la preparacion de compuestos azabiciclicos.

Also Published As

Publication number Publication date
ES2147749T3 (es) 2000-10-01
TW224466B (ko) 1994-06-01
HK1012366A1 (en) 1999-07-30
DK0626961T3 (da) 2000-11-06
GR3034295T3 (en) 2000-12-29
EP0984008A2 (en) 2000-03-08
ATE194341T1 (de) 2000-07-15
AU669355B2 (en) 1996-06-06
ZA931132B (en) 1993-10-14
EP0626961A1 (en) 1994-12-07
MX9300875A (es) 1993-08-31
US6596869B2 (en) 2003-07-22
AU3460793A (en) 1993-09-13
GB9203688D0 (en) 1992-04-08
US20020143185A1 (en) 2002-10-03
WO1993017018A1 (en) 1993-09-02
JPH07504180A (ja) 1995-05-11
US5545740A (en) 1996-08-13
JP3288704B2 (ja) 2002-06-04
PT626961E (pt) 2000-10-31
NZ246940A (en) 1996-06-25
EP0984008A3 (en) 2000-05-03
EP0626961B1 (en) 2000-07-05
DE69328962T2 (de) 2000-12-28
KR100261530B1 (ko) 2000-08-01
CA2131019A1 (en) 1993-08-21
DE69328962D1 (de) 2000-08-10
CA2131019C (en) 2002-12-24

Similar Documents

Publication Publication Date Title
KR950700292A (ko) 니트로소화방법(Nitrosation process)
FI931888A0 (fi) Kramploesande cykliska fruktopyranossulfiter -och sulfater
ES2054826T3 (es) Peptidos con actividad inhibidora de colagenasa.
EP0742209A3 (en) Process for the preparation of an optically active quinoline demevalonolacton and process for the preparation of a salt of an optically active quinoline demevalolon
HUT57043A (en) Process for producing pharmaceutical solutions comprising macrolide
DE69027440D1 (de) Bizyklische pyrimidinderivate, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzung
HU906029D0 (en) Process for the preparation of pleuromuthylyne derivatives
MX21088A (es) N-heteroanil-purin-6-aminas, y un proceso para su preparacion y su uso como medicamentos.
ATE122042T1 (de) Pyrazoloisoquinoline-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
FI895185A0 (fi) Mevalonolaktoner av tienopyridintyp.
DK154837C (da) Oxadiazolylimidazobenzodiazepinforbindelse og farmaceutisk praeparat indeholdende samme
DE69401163D1 (de) Umwandlungsverfahren von Lorabef Dihydrate in Loracarbef Monohydrate
FI933928A0 (fi) Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel
CA2193310A1 (fr) Nouveau derive de 4-imidazolidinone, son procede de preparation et les compositions pharmaceutiques qui les contiennent
PT92355A (pt) Processo para a preparacao de derivados de di-hidro-piridina
ES2128304T3 (es) Procedimiento para preparar 5-arilhidantoina.
ATE78489T1 (de) Kristallinische n-(s-3-methylheptanoyl)-d-gammaglutamyl-glycyl-d-alanine und deren verfahren und zwischenverbindungen.
DK162188A (da) Fremgangsmaade til fremstilling af pentandionderivater
TH13944EX (th) สารประกอบเฮเทโรไซคลิค

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20060331

Year of fee payment: 7

LAPS Lapse due to unpaid annual fee